RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/8366F60D73B5186E7CD04379577338A2103E41460DC3F6B91F14A98798EA9C01011E2F92EC8C952088549BB6A291A372http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/8366F60D73B5186E7CD04379577338A2103E41460DC3F6B91F14A98798EA9C01011E2F92EC8C952088549BB6A291A372http://www.w3.org/2000/01/rdf-schema#comment"we observed time points where surface CXCR4 appeared fully occupied but MEDI3185 was not detectable in serum. These paradoxical results represented a type of assay interference and by comparing pharmacokinetic ADA and total CXCR4 results the most likely reason for the free CXCR4 results was the emergence of neutralizing anti-drug antibodies (ADA)."xsd:string
http://purl.uniprot.org/uniprot/#_A1CE88A4AE284DF73D14BCDD40E803904965449ED63A860077861C4BC18820A88EBC4C30DB932651034156F0593B64FEhttp://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/8366F60D73B5186E7CD04379577338A2103E41460DC3F6B91F14A98798EA9C01011E2F92EC8C952088549BB6A291A372
http://purl.uniprot.org/uniprot/P61073http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/8366F60D73B5186E7CD04379577338A2103E41460DC3F6B91F14A98798EA9C01011E2F92EC8C952088549BB6A291A372
http://purl.uniprot.org/uniprot/#_P61073-mappedCitation-26384735http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/8366F60D73B5186E7CD04379577338A2103E41460DC3F6B91F14A98798EA9C01011E2F92EC8C952088549BB6A291A372